Tag
Kobo Biotech Limited
2 articles
Kobo Biotech FY25 Net Loss ₹52.3M Under CIRP
Kobo Biotech Ltd. submitted its FY 2024-25 Annual Report while under Corporate Insolvency Resolution Process (CIRP) initiated by NCLT in August 2024.
The company reported a net loss of ₹52.3 million f
Kobo Biotech FY24 Loss ₹49.28L, CIRP Initiated Post-Year
Kobo Biotech submitted its FY24 Annual Report under SEBI Regulation 34 while under Corporate Insolvency Resolution Process (CIRP) initiated in August 2024.
The company reported zero operational revenu